Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
2008 · Molecular Therapy · 1,763 citations
https://doi.org/10.1038/mt.2008.200
H
Hiromi Muramatsu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
130
Papers
12.1K
Citations
36
h-index
67
i10-index
Hiromi Muramatsu is an academic researcher from California University of Pennsylvania. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & RNA Interference and Gene Delivery & Immunotherapy and Immune Responses. The author has an h-index of 36, co-authored 111 publications.
ORCID: 0000-0003-1544-1493Papers by this author
worksAdministration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 · Nature Communications · 335 citations
https://doi.org/10.1038/ncomms14630
Molecular fate-mapping of serum antibody responses to repeat immunization
2023 · Nature · 168 citations
https://doi.org/10.1038/s41586-023-05715-3
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 · Science Advances · 168 citations
https://doi.org/10.1126/sciadv.ade1444
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
2019 · Molecular Therapy — Nucleic Acids · 103 citations
https://doi.org/10.1016/j.omtn.2019.03.003
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis
2023 · Cell stem cell · 40 citations
https://doi.org/10.1016/j.stem.2023.10.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat